Fig. 4.
Effect of anti-TRAIL mAb on apoptosis of PBMCs from AML patients and cord blood CD34+ cells following coculture with activated CD4+Vα24NKT cells derived from Pt 1.
Early apoptosis of the PBMCs from Pt 1 (M4) and Pt 4 (M1) and cord blood CD34+ cells was defined by AV+PI− cells in the presence of anti-TRAIL mAb, RIK-2 (white column), or IgG1 isotype control (shadow column). The results are expressed as mean ± SD (n = 3) of the percentage of AV+PI− cells.